Novel Test for T Cell Immunotherapy

This is a news story, published by ScienceDaily, that relates primarily to Shou Kit Hang news.

Shou Kit Hang news

For more Shou Kit Hang news, you can click here:

more Shou Kit Hang news

biology news

For more biology news, you can click here:

more biology news

ScienceDaily news

For more news from ScienceDaily, you can click here:

more news from ScienceDaily

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about

cancer immunotherapy applications

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest tumour cells news, immunotherapy outcomes news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Immunotherapy Advances

ScienceDaily

•

Scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness

Summary

Nutrition label

80% Informative

New test requires only a small blood sample to track modified T cells in patients over time, ensuring therapies remain effective.

This plug-and-play approach is set to accelerate the development of more T-cell-based therapies and vaccines.

Originally designed to detect SARS-CoV-2-specific T cells, this technology has now been adapted for use in cancer immunotherapy applications.

The SAFE-T-HBV clinical trial was sponsored by Lion TCR Pte Ltd. Story Source: Journal Reference: - Anthony T Tan, Shou Kit Hang , Nicole Tan , Thinesh L Krishnamoorthy , Wan Cheng Chow , Regina Wanju Wong , Lu-En Wai , Antonio Bertoletti . A rapid method to assess the in vivo multi-functionality of adoptively transferred engineered TCR T cells. Immunotherapy Advances, 2024 ; 4 ( 1 ) DOI: 10.1093 /immadv/ltae007 Cite This Page:.